ch.oddb.org
  
Wala Echinacea Mund- und Rachenspray, Spray zur Anwendung in der Mundhöhle - 50 ml
48473002 WALA Schweiz AG
Wala Echinacea Mund- und Rachenspray, Spray zur Anwendung in der Mundhöhle27.04.1988
  27.04.1988
Various (A01AD11)15.05.2003
WHO-DDD 
20.02.50 ml
20.02. 
D  
No 
  CI
PR  
k.A.PR
   
  Anthroposophische Arzneimittel
   
Composition
echinacea pallida ex herba rec. LA 20% (HAB 12c) 100 mg, calendula officinalis e floribus rec. LA 20% (HAB 12c) 100 mg, salvia officinalis e foliis recens LA 20% (HAB 12c) 100 mg, argenum nitricum D13 aquos. (HAB 5b) 10 mg, eucalyptus globulus e foliis rec. ferm 33d D1 (HAB 33d) 10 mg, gingiva bovis Gl D4 (HAB 41b) 10 mg, gingiva bovis Gl D8 (HAB 41b) 10 mg, tonsillae palatinae bovis Gl D4 (HAB 41a) 10 mg, tonsillae palatinae bovis Gl D8 (HAB 41a) 10 mg, aqua purificata, ethanolum 96 per centum, acidum citricum monohydricum, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, ad solutionem pro 1 ml, corresp. 5-6 doses, corresp. ethanolum 18 % V/V.
Packungsbestandteile
Spray zur Anwendung in der Mundhöhle
 
 
Active AgentDose
Argenum Nitricum D13 Aquos. (Hab 5B)10 mg/ml
Calendula Officinalis e Floribus rec. la 20% (Hab 12c)100 mg/ml
Echinacea Pallida ex Herba rec. la 20% (Hab 12c)100 mg/ml
Eucalyptus Globulus e Foliis rec. ferm 33d D1 (Hab 33d)10 mg/ml
Gingiva Bovis gl D4 (Hab 41b)10 mg/ml
Salvia Officinalis e Foliis Recens la 20% (Hab 12c)100 mg/ml
Tonsillae Palatinae Bovis gl D8 (Hab 41a)10 mg/ml
 
Inactive agentsDose
Citric Acid Monohydrate 
Aqua Purificata 
Ethanol96
Gingiva Bovis gl D8 (Hab 41b)10 mg/ml
Sodium Chloride 
Sodium Hydrogen Carbonate 
Per Centum 
Tonsillae Palatinae Bovis gl D4 (Hab 41a)10 mg/ml
Source
Data was imported : 07.10.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Help | FAQ | Contact | Home